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Antimicrobial use for selected diseases in cats in Switzerland  
 
Antibiotic use in human and veterinary medicine is considered a main driver of antimicrobial 
resistance development. Although guidelines to promote appropriate use of antimicrobials in 
veterinary patients have been developed, antibiotic overprescription is assumed to be a common 
problem. The goal of this study was to investigate antimicrobial use in cats with acute upper 
respiratory tract disease (aURTD), feline lower urinary tract disease (FLUTD) and abscesses, and 
to assess compliance of prescription with consensus guidelines. A total of 776 cases (aURTD, 
n=227; FLUTD, n=333; abscesses, n=216) presented to two university hospitals and 14 private 
veterinary practices in Switzerland during 2016 were retrospectively evaluated.  
A total of 60– 96% of the cats received antibiotic therapy. Prescriptions were in complete 
accordance with the guidelines in only 17–24% of the cases. The critically important third 
generation cephalosporins were the second most frequently prescribed antibiotic class and were 
used in 25–28% of the cases. Although diagnostic work-up was more common at the university 
hospitals, overall frequency of antimicrobial treatment was not different, and antibiotic 
prescription was not clearly superior compared to private practices. 
Our results indicate that overprescription of antibiotics in cats is common and accordance with 
guidelines is poor. The study highlights the need to promote antimicrobial stewardship in small 
animal medicine.  
 
Keywords: antibiotic prescription; antimicrobial stewardship; resistance; cat; infection 
 
 
 
5 
 
Vetsuisse Fakultät Universität Zürich (2019) 
 
Kira Schmitt 
 
Institut für Veterinärpharmakologie und –toxikologie, sekretariat@vetpharm.uzh.ch 
Klinik für Kleintiermedizin, sekretariat@kltmed.ch 
 
Antibiotikaeinsatz für ausgewählte Krankheiten bei Katzen innerhalb der Schweiz 
 
Antibiotikaeinsatz in der Human- und Veterinärmedizin gilt als Haupttreiber für die Entwicklung 
antimikrobieller Resistenzen. Obwohl in der Veterinärmedizin Leitlinien zur Förderung eines 
umsichtigen Antibiotikaeinsatzes entwickelt wurden, wird vermutet, dass Antibiotika übermässig 
verschrieben werden. Ziel dieser Studie war es, die Antibiotikaverschreibung bei Katzen mit 
akuter Erkrankung der oberen Atemwege (aURTD), Erkrankung der unteren Harnwege (FLUTD) 
und Abszessen zu untersuchen und die Übereinstimmung mit Konsensus-Leitlinien zu 
überprüfen. Insgesamt wurden 776 Fälle (aURTD, n=227; FLUTD, n=333; Abszesse, n=216), 
die 2016 an zwei Universitätsspitälern und 14 Privatpraxen in der Schweiz vorstellig wurden, 
retrospektiv ausgewertet. 
Insgesamt erhielten 60–96% der Katzen eine Antibiotikatherapie. Nur in 17–24% der Fälle 
entsprachen die Verschreibungen den Leitlinien. Die kritisch wichtigen Cephalosporine der 
dritten Generation wurden am zweithäufigsten verschrieben und wurden in 25–28% der Fälle 
angewendet. Obwohl die diagnostische Aufarbeitung der Fälle an den Universitätsspitälern 
häufiger war als in den Privatpraxen, unterschied sich die Frequenz der Antibiotikabehandlung 
nicht und die Antibiotikaverschreibung war nicht besser. 
Die Ergebnisse deuten darauf hin, dass Antibiotikaverschreibung bei Katzen häufig und 
Übereinstimmung mit Leitlinien schlecht ist. Die Studie unterstreicht die Notwendigkeit, 
umsichtigen Antibiotikaeinsatz in der Kleintiermedizin zu fördern. 
 
Stichworte: Antibiotikaverschreibung; Resistenz; Katze; Infektion 
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Abstract 
Background: Antibiotic use in human and veterinary medicine is considered a main 
driver of antimicrobial resistance development. Although guidelines to promote 
appropriate use of antimicrobials in veterinary patients have been developed, antibiotic 
overprescription is assumed to be a common problem. The goal of this study was to 
investigate antimicrobial use in cats in Switzerland with acute upper respiratory tract 
disease (aURTD), feline lower urinary tract disease (FLUTD) and abscesses, and to 
assess compliance of prescription with consensus guidelines. A total of 776 cases 
(aURTD, n=227; FLUTD, n=333; abscesses, n=216) presented to two university 
hospitals and 14 private veterinary practices in Switzerland during 2016 were 
retrospectively evaluated. Clinical history, diagnostic work-up and antimicrobial 
prescription (class, dosage, duration) were assessed. 
Results: A total of 77% (aURTD), 60% (FLUTD) and 96% (abscesses) of the cases 
received antibiotic therapy; 13–24% received combination or serial therapy. The cats 
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were treated for a median of 7 (abscesses) and 10 days (aURTD, FLUTD). Treatments 
with potentiated aminopenicillins (40–64%), third generation cephalosporins (25–28%), 
aminopenicillins (12–24 %) and fluoroquinolones (3–13%) were most common. 
Prescriptions were judged in complete accordance with consensus guidelines in 22% 
(aURTD), 24% (FLUTD) and 17% (abscesses) of the cases. The presence of lethargy, 
anorexia or fever in cats with aURTD (p=0.002), and the detection of bacteriuria in cats 
with FLUTD (p<0.001) were associated with antibiotic therapy. Although diagnostic 
work-up was more common (aURTD and FLUTD: p<0.001) and the use of critically 
important antibiotics less common (aURTD: p=0.001; FLUTD: p<0.001) at the university 
hospitals compared to private practices, the frequency of antibiotic treatment was not 
different between the university hospitals and private practices.  
Conclusion: Our results indicate that overprescription of antibiotics in cats in 
Switzerland is common and accordance with guidelines is poor. The study highlights the 
need to promote antimicrobial stewardship in small animal medicine.  
 
Keywords: antibiotic prescription; antimicrobial stewardship; resistance; guidelines; 
acute upper respiratory tract disease; feline lower urinary tract disease; FLUTD; 
abscess; infection 
 
Background 
Mitigation of antimicrobial resistance has been an emerging topic that plays an important 
role in human and veterinary medicine. Antimicrobial resistance in bacteria is a naturally 
occurring phenomenon and has been subject to evolution over millions of years [1–5]. 
The frequent use of antimicrobials in human and veterinary medicine and in agriculture 
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exerts an enormous selection pressure on bacterial populations and promotes the 
development of multidrug-resistant bacteria that can readily spread their resistance 
genes by various mechanisms [1–3]. Antibiotic use in veterinary medicine is discussed 
as one of the main drivers for resistance development. In Europe, around 8,000 tons of 
antibiotics were sold for veterinary use in 2015, with pronounced differences between 
countries [6]. The amount of antibiotics used in companion animals in Europe in 
comparison to the amount prescribed in livestock is relatively small [6], but is not to be 
neglected. The close contact of pets with their owners facilitates the transmission of 
multidrug-resistant organisms between human and companion animals [1, 7–14]. 
Furthermore, the trend for intensive medical care of dogs and cats poses a risk for 
nosocomial infections [15–18] and is associated with an increasing number of geriatric 
and immunosuppressed patients that are highly susceptible to infections with multidrug-
resistant bacteria.  
Based on recent data, Centres for Disease Control and Prevention estimates that 
approximately 30 ̶ 50% of antibiotic prescriptions in humans are unnecessary [19, 20]. 
Surveys describing antimicrobial use in dogs and cats revealed that antibiotics are 
frequently prescribed, in particular beta-lactam antibiotics [21–30], and that cats are 
especially exposed to the critically important third generation cephalosporins [21–25, 
30–33]. Most previous studies performed in dogs and cats were based on 
questionnaires presenting hypothetical scenarios that have been sent out to 
veterinarians [22, 23, 28, 33–37]. These studies are commonly hampered by a selection 
bias, recall bias and prevarication bias, and the answers given do not necessarily reflect 
the actual prescribing practice. Some studies analyzed pharmacy records [38, 39] and 
veterinary or pet insurance databases [21, 22, 24–27, 29, 30, 32] but only few studies 
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evaluated whether prescriptions practice was in accordance with relevant guidelines [24, 
26, 27, 33, 34].  
The aims of this study were to investigate the antimicrobial prescribing practice in 
Switzerland for indications in cats with frequent use of antibiotics, i.e., in cases of acute 
upper respiratory tract disease (aURTD), feline lower urinary tract disease (FLUTD) as 
well as abscesses, and to evaluate to what extend the prescriptions comply with recently 
established consensus guidelines [40, 41]. 
 
Methods 
Cases presented between January 1st and December 31st 2016 to the two Swiss 
university teaching hospitals for small animals (Vetsuisse Faculty Bern and Zurich) as 
well as to fourteen private veterinary practices across Switzerland were included. The 
private practices participated on a voluntary basis following a nationwide call. In order to 
identify patients matching the inclusion criteria (Table 1), the electronic records were 
scanned for predetermined search terms (Table 1) using search functions provided by 
the particular software. For practical reasons, only private practices using either 
OblonData® (Amacker&Partner Informatik AG, Zurich, Switzerland) or Diana SUISSE® 
(Diana Software AG, Zurich, Switzerland) were enrolled. A full text search was 
conducted and the matches were manually reviewed. All cases from the two university 
hospitals matching the criteria were included. From private practice, 16 cases per 
indication that matched the criteria were randomly selected via the sampling function of 
Microsoft Excel. In eight private practices, less than 16 cases per indication were found 
in the case files and included. 
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Signalment, vaccination status, clinical history, reports on clinical examination, 
antibiotic pretreatment, diagnostic work-up, comorbidities, hospitalization and 
antimicrobial therapy (substance class, dose, frequency of application and duration of 
therapy) were retrieved from the medical records. The evaluated diagnostic work-up for 
aURTD included PCR for feline calicivirus (FCV) and feline herpesvirus-1 (FHV); for 
FLUTD, urine sediment analysis and urine bacterial culture were assessed. Bacteriuria 
was defined as the presence of bacteria in the urine sediment analysis or in the bacterial 
culture from an aseptically collected urine sample (cystocentesis or catheterized 
sample). Complicated urinary tract infections were defined as infections that were 
caused by anatomical or functional changes or a comorbidity, that predispose the 
patient to persistent or recurrent infections or treatment failure [42]. Critically important 
antibiotics comprised third or higher generation cephalosporins, quinolones, macrolides, 
ketolides, glycopeptides and polymyxins [43]. Combination therapy was defined as the 
prescription of two or more antibiotic classes at the same time; serial therapy as the 
prescription of one antibiotic class followed by a different antibiotic class. Antimicrobial 
prescription was compared with the consensus guidelines summarized in Table 2 using 
a previously published justification score (JS) with modifications shown in Table 3 [44]. 
The guidelines were published in December 2016 [40] and can be accessed online as 
the AntibioticScout tool [45].  
For statistical analysis, the commercially available SPSS® software (SPSS Inc, IL, 
USA) was used. Descriptive statistics and comparisons of groups were conducted. 
Because the continuous variables were not normally distributed, the Mann Whitney U 
Test was used to compare the median age as well as the duration of therapy between 
the university hospitals and private practices. For the median age, 95% confidence 
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intervals (CI) were calculated. The Chi square test was performed for categorical 
variables (case characteristics, diagnostic work-up, hospitalization, antibiotic 
pretreatment and antibiotic prescription) between university hospitals and private 
practices; frequency of antibiotic therapy between the indications; association of 
symptoms listed in the guidelines (for aURTD and abscesses) or the presence of 
bacteriuria (for FLUTD) with antibiotic therapy. The level of significance was set at 
p<0.05. For the comparison of the justification scores between university hospitals and 
private practices the Chi square test was performed and the significance level was 
adapted for multiple tests using the Bonferroni correction. 
 
Results 
Case characteristics 
A total of 776 cats were included in the study. Case characteristics are shown in Table 
4. A detailed overview of clinical symptoms, diagnostic procedures and antimicrobial 
prescription for each indication is given in Tables 5–7. Cats with aURTD were 
significantly younger (median age: 3 years) than cats with FLUTD (median age: 8 years, 
p<0.001) or cats with abscesses (median age: 7 years; p<0.001) and more likely to be 
intact (aURTD and FLUTD: p<0.001, aURTD and abscesses:  p<0.001). Furthermore, 
the cats presented to the university hospitals were more often pretreated with antibiotics 
and hospitalized when compared with the cases in private practices (pretreatment: 
aURTD and FLUTD, p<0.001; hospitalization: aURTD and FLUTD, p<0.001). The 
frequency of antibiotic prescription differed between the indications (percentage of cases 
treated: aURTD, 77%; FLUTD, 60%; abscesses, 96%; p<0.001), but was not 
significantly associated with breed, age or sex of the cats.  
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Antibiotic prescription for aURTD 
Of 227 cats with aURTD, 175 (77%) received antibiotic therapy with the following 
substance classes: potentiated aminopenicillins (40%), third generation cephalosporins 
(28%), aminopenicillins (24%), tetracyclines (16%), fluoroquinolones (4%), amphenicols 
(2%), macrolides (2%), first generation cephalosporins and penicillins (1% each); 15% of 
the cases received combination or serial therapy. The cats were treated for 4 to 37 days 
(median of 10 days). Antibiotic therapy was significantly associated with the indications 
listed in the guidelines (presence of lethargy, anorexia or fever, p=0.002). The treatment 
decision was judged as being compliant with the guidelines (JS-1) in 49 cases (22%) 
and not in accordance with the guidelines in 135 cases (59%; JS-2: n=4, 2%; JS-3: 
n=48, 21%; JS-4, n=83, 36%). The lack of information on the presence or absence of 
disease symptoms as listed in the guidelines precluded judgment in 43 cases (19%). 
Judgement of antimicrobial prescription was significantly more often not possible in 
private practices compared to the university hospitals (p=0.001). 
The diagnostic work-up and antimicrobial prescription patterns differed between 
private practices and university hospitals (Table 5). The aURTD cases were significantly 
more frequently tested by PCR for the presence of respiratory pathogens at the 
university hospitals compared to private practices (p<0.001). The choice of antibiotic 
(JS-3) was significantly more often in disagreement with the guidelines at the university 
hospitals (p<0.001); this was mainly due to the more common use of potentiated 
aminopenicillins (p<0.001) and the less common use of aminopenicillins (p=0.002) at the 
university hospitals compared to private practices. On the other hand, the use of 
critically important antibiotics was significantly more common in private practices 
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(p=0.001). The decision to use antibiotics for treatment was significantly more often in 
disagreement with the guidelines (JS-4) in the private practices (p=0.001).  
Antibiotic prescription for FLUTD 
Of 333 cats with FLUTD, 200 cases (60%; 56 with bacterial cystitis, 144 with 
other/unknown diagnosis) received antibiotic therapy with the following substance 
classes: potentiated aminopenicillins (61%), third generation cephalosporins (26%), 
fluoroquinolones (13%), aminopenicillins (12%), first generation cephalosporins (3%), 
amphenicols (1%) and tetracyclines (1%); 13% received combination or serial therapy. 
The cats were treated for 1 to 56 days (median of 10 days). The presence of bacteriuria 
was significantly associated with antibiotic therapy (p<0.001). The treatment decision 
was judged as being compliant with the guidelines (JS-1) in 81 (24%) and not in 
accordance with the guidelines in 82 (25%) cases (JS-2: n=1, 1%; JS-3: n=31, 9%; JS-
4: n=50, 15%). Inadequate diagnostic work-up (154 out of 170 cases, 91%) was the 
main reason to preclude judgment in 170 cases (51%).  
Diagnostic work-up and antimicrobial prescription patterns were again different 
between the university hospitals and private practices (Table 6). Urine sediment analysis 
or bacterial culture were significantly more commonly performed at the university 
hospitals compared to private practices (p<0.001). Antimicrobial prescription at 
university hospitals was significantly more often graded as JS-1 (complete agreement 
with the guidelines, p<0.001), JS-3 (choice of antimicrobial different from the guidelines, 
p<0.001) and JS-4 (complete discrepancy with the guidelines, p<0.001) compared to 
prescriptions at private practices. The use of critically important antibiotics was 
significantly more common in private practice compared to the university hospitals 
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(p<0.001). Furthermore, judgment of antimicrobial prescription was significantly more 
often not possible in private practices (p<0.001). 
Antibiotic prescription for abscesses 
Of 216 cats with abscesses, 207 cats (96%) received antibiotic therapy with the 
following substance classes: potentiated aminopenicillins (64%), third generation 
cephalosporins (25%), aminopenicillins (24%), first generation cephalosporins (6%), 
fluoroquinolones (3%), lincosamides (2%), penicillins (1%); 24% received combination 
or serial therapy. The cats were treated for 1 to 24 (median 7) days. Local wound 
treatment was carried out in 156 of 216 cases (72%) and drains were placed in 33 of 
216 cases (15%). Antibiotic therapy was not associated with any of the symptoms listed 
in the guidelines, i.e., signs of generalization, poor general condition, severely 
contaminated wounds, and/ or proximity to delicate tissues. Antimicrobial therapy was 
judged in accordance with the guidelines (JS-1) in 36 (17%) and not in accordance with 
the guidelines in 95 (44%) cases (JS-2: n=16, 7%; JS-3: n=14, 7%; JS-4: n=65, 30%). 
Assessment of prudent use was not possible 85 cases (39%). 
 
Discussion  
The results of this study indicate that overprescription of antibiotics in cats in Switzerland 
with aURTD, FLUTD and abscesses is very common. Although the diagnostic work-up 
was more elaborate at the university hospitals, and critically important antibiotics were 
less commonly prescribed at the universities, the prudent use pattern of prescriptions 
was not clearly superior compared to private practices. This was mainly due to the very 
common use of potentiated aminopenicillins instead of non-potentiated aminopenicillins 
at the universities. On the other hand, the quality of antimicrobial prescription could often 
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not be judged in the cases from private practices because the diagnostic work-up or the 
symptoms of the patients were often not documented. The common discrepancy of 
antimicrobial prescription with recently established consensus guidelines [40, 41] at the 
two university hospitals is surprising considering that senior clinicians of these hospitals 
were involved in the drafting of the guidelines. The overall frequency of antimicrobial 
treatment was also not different at the university hospitals compared to private practices. 
However, our data indicates that the animals presented to the university hospitals were 
more often pretreated or hospitalized, and could thus have been in a more debilitated 
condition.  
Only 17 ̶ 24% of the treatment decisions in this study were classified as JS-1 and 
therefore in complete accordance with the consensus guidelines. Recent studies in dogs 
and cats have reported an overall agreement of 0–69% with published guidelines [24, 
27, 33, 34]. This overall low accordance raises the question of whether the proposed 
guidelines cannot be implemented in clinical practice, for example, due to poor market 
availability of appropriate antibiotic formulations, or whether the content is not well 
disseminated among veterinary practitioners. The consensus guidelines used in this 
study are available online and easily accessible, but they were only introduced by 
December 2016. The a priori compliance with the proposed guidelines was evaluated in 
this study to lay the basis to monitor, in a next step, the impact of these guidelines on 
antimicrobial prescription patterns in Switzerland. 
The critically important antibiotics used in cats in this study were mostly third 
generation cephalosporins as well as fluoroquinolones. Third generation cephalosporins 
were the second most frequently prescribed antibiotic class and were used in 25–28% of 
the cases. This mirrors the results obtained in previous studies [21–25, 31–33] and 
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could likely be explained by the convenient application (as a single subcutaneous 
injection) and the long dosing interval (two weeks) of the authorized product in 
Switzerland (cefovecin, Convenia®, Zoetis, Delémont, Switzerland). A previous study 
evaluating electronic health records found that inability to orally medicate the cat was 
the most common reason given for prescribing cefovecin [46]. An online survey in 
veterinarians in Switzerland also revealed that the route of application was the most 
important factor in the choice of antimicrobial therapy in cats [47]. In our study, the 
prescription of critically important antibiotics was significantly more frequent in private 
practices compared to the university hospitals. This observation supports the hypothesis 
that the workplace environment is an important factor determining treatment decisions 
and antimicrobial use [48]. University hospitals, as training centers, may have stronger 
restrictions for the use of critically important antibiotics: one of the two university 
hospitals of this study completely forbids the use of third generation cephalosporins in its 
patients. On the other hand, the cats at the university hospitals were more commonly 
hospitalized compared to the cases in private practices, thus allowing for parenteral 
medication and avoiding the problem of oral application of the antibiotic drug.  
 Antimicrobial prescription in the absence of proper diagnostic work-up was very 
common in this study. In only 40% of the FLUTD cases overall, and in only 10% of the 
FLUTD cases in private practices, bacterial culture and susceptibility testing were 
carried out. In a previous study based on a questionnaire, 32.5% of companion animal 
practitioners in Europe reported that they frequently undertake antimicrobial 
susceptibility testing whereas 9.1% never demand such tests [49]. In another survey 
from Italy, 91% of the practitioners reported to carry out microbiological analysis, 
although only 20% reported to do so frequently [35]. Our results indicate that these data 
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based on questionnaires are probably too optimistic and that bacterial culture, an 
essential diagnostic work-up step for cats with FLUTD, is rarely performed in private 
practices. In contrast, bacterial culture was performed in 87% of the FLUTD cases 
presented to the university hospitals, although this did not result in a less frequent 
prescription of antimicrobials. Interestingly, 56% of the FLUTD cases at the universities 
received antibiotic therapy despite the absence of bacteria in urine culture. A total of 
20% of these cats were pretreated with antibiotics which could have affected the 
interpretation of a negative bacterial culture result. Also many of these cats suffered 
from urinary tract obstruction and antibiotic therapy was initiated after removal of the 
indwelling urinary catheter.  
The trend towards more diagnostic testing at the university hospitals is also 
demonstrated by a more frequent use of PCR for the detection of FCV and FHV in 
cases with aURTD. These tests can be useful to support a diagnosis of viral infection 
and to initiate supportive measures such as the prescription of famciclovir in the case of 
FHV infection, and thus reduce the use of antibiotics [50]. In this study, the detection of 
FCV and FHV did not affect the frequency of antibiotic prescription. Overprescription of 
antibiotics in cats with aURTD was common in both groups: although only 29% of the 
cats showed symptoms that would have justified an antibiotic therapy according to the 
consensus guidelines, 77% of the cases received antibiotic treatment. Potentiated 
aminopenicillins were most often prescribed at the university hospitals, while third 
generation cephalosporins and aminopenicillins were most commonly used in private 
practice. A study revealed that amoxicillin with clavulanic acid is not superior to 
doxycycline when treating cats with signs of acute respiratory tract disease [51]. Our 
data, however, indicate that the cases presented to the university hospitals were in a 
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more debilitated condition, because 72% of the cats with aURTD were hospitalized in 
comparison to 3% in private practices. Furthermore, 68% of the cats presented to 
university hospitals had symptoms listed in the guidelines, while at the private practices 
only 21% of the cats were reported to show a poor general condition, fever, lethargy 
and/ or anorexia. The more compromised clinical condition of the patients at university 
hospitals could explain the common use of aminopenicillins instead of doxycycline due 
to the lack of a licensed injectable doxycycline preparation in Switzerland. However, 
potentiated instead of non-potentiated aminopenicillins were almost exclusively used at 
the universities. Non-potentiated and potentiated aminopenicillins are often used 
interchangeably although it has been shown that the use of clavulanic acid may increase 
AmpC-mediated resistance causing inducible organisms to become insensitive to 1st to 
3rd generation cephalosporins [52, 53]. The frequent use of potentiated aminopenicillins 
instead of non-potentiated aminopenicillins in this study could also be due to the better 
availability of these products on the market, since they make up the largest part of 
antimicrobial compounds licensed for cats in Switzerland [54]. 
A total of 96% of the cats with abscesses received antibiotic treatment but only 
30% of the cats presented symptoms that, according to the guidelines, would justify an 
antibiotic therapy. Our findings are in line with results from previous studies where 
frequency of antibiotic prescriptions for skin diseases such as wounds or abscesses 
ranged from 90–97% of cases [24, 32]. In children, antibiotics might sometimes be 
applied for local wound treatment to avoid anesthesia or sedation [55]. However, 72% of 
the cats in this study received local wound treatment and passive drains were placed in 
15% of the cats. It can be assumed that, in many of these cases, antibiotics were 
supplemented as a preventative measure. Studies from human medicine showed that 
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appropriate drainage of the abscess is important and that antibiotic treatment may not 
be necessary [56–59]. Several guidelines for small animals state that an antibiotic 
treatment is not indicated if the abscess is well-defined and the animal is in a good 
general condition [60–62]. 
The present study has some limitations. The insufficient documentation in the 
databases limited the information available for review. The presence of bacteria in urine 
sediment analysis of an aseptically collected urine sample was considered appropriate 
to confirm a bacterial etiology in cases with FLUTD, although this is considered 
insufficient diagnostic work-up according to some guidelines due to the variable quality 
of interpretation, the risk of stain contamination as well as the possibility of false positive 
results [61, 63]. In a recent study, overall accuracy of in-house microscopic evaluation 
for bacteriuria in primary practice was only 64.5% when comparing results to reference 
bacterial cultures [64]. We decided to consider these results since former studies have 
reported accuracies of urine sediment analysis of 97–98% when performed by 
experienced laboratory personal [65–68]. Furthermore, the generally low prevalence of 
bacterial cystitis in cats should not result in many false positive results [69–71]. 
The assessment score used in this study leaves a margin of interpretation and 
the justification of antimicrobial prescription was based on consensus guidelines 
released in Switzerland. Results could differ to some extent when comparing 
prescription to guidelines from other countries. Also, there could be a selection bias 
since the participation in this study was on a voluntary basis and the enrolled practices 
might have been more aware of antimicrobial resistance and more likely to prescribe 
antibiotics prudently.  
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Conclusion 
The present study highlights the need to promote antimicrobial stewardship in small 
animal medicine and to implement effective intervention strategies. Particular attention 
should be paid to the education of veterinarians, the propagation of diagnostic work-up 
and the need for proper documentation to justify antibiotic treatment. Antimicrobial 
stewardship at universities should be urgently advanced as they serve as role models 
for veterinary practice. Developments on the market to provide small spectrum 
antibiotics for convenient application would be of particular importance in cats since the 
route of application is a major factor in the choice of antimicrobials in this species. Such 
new products will contribute to ensuring that effective antimicrobials remain available in 
the future to combat bacterial infections in human and veterinary medicine.  
 
List of abbreviations:  
aURTD: acute upper respiratory tract disease 
FLUTD: feline lower urinary tract disease 
PCR: polymerase chain reaction 
FCV:  Feline Calicivirus  
FHV: Feline Herpesvirus-1  
JS: justification score 
vs: versus 
n.s.: not significant 
SID: once daily 
BID: twice daily 
TID: three times daily 
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Tables 
Table 1: Inclusion and exclusion criteria and search terms for aURTDa, FLUTDb and abscesses 
Indication Inclusion criteria Exclusion criteria Search terms 
aURTDª Nasal discharge with infectious 
or unknown etiology lasting no 
longer than two weeks  
Evidence of fungal infection, 
neoplasia or involvement of the 
lower respiratory tract 
Upper respiratory tract infection, 
rhinotracheitis, rhinitis, sinusitis, 
nasal discharge, sneezing, 
coughing, stridor, dyspnoea, 
dyspnoea, tachypnoea, tachypnoe, 
cat flu, herpes, Calici, 
Mycoplasma, Chlamydia, laryngitis 
FLUTDb Stranguria, pollakisuria, periuria, 
pigmenturia or dysuria  and a 
diagnosis of bacterial cystitis, 
bladderstones, urethrastones, 
urethral plugs, idiopathic cystitis 
Involvement of the upper urinary 
tract 
Lower urinary tract disease, 
FLUTDb, pollakiuria, polyuria, 
anuria, stranguria, dysuria, 
hematuria, bloody urine, urinary 
stones, bladder stones, urolithiasis, 
concrements, cystitis, urethra 
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or cystitis of unknown origin obstruction, urinary tract infection, 
UTI, urinary incontinence 
Abscess Bite abscesses or abscesses of 
unknown origin 
 
Anal gland abscesses, tooth root 
abscesses, foreign body 
abscesses 
Abscess, bite wound, bite, pus  
ªaURTD, acute upper respiratory tract disease; bFLUTD, feline lower urinary tract disease  
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Table 2: Consensus guidelines [40, 41] used to evaluate prudent use of antimicrobials 
Indication Comment Antibiotic  Dosage 
(mg/kg/d) 
Application 
frequency  
Treatment duration 
(days) 
aURTD Antibiotic therapy is only 
indicated if poor general 
condition, fever, lethargy and/ 
or anorexia are present 
Doxycycline   10 / 5 SIDb/ BIDc 5 ̶ 14 
Amoxicillin 15 ̶ 20  BIDc/ TIDd 5 ̶ 14 
FLUTD Complicated UTIª are defined 
as infections that are caused 
by anatomical or functional 
changes or disorders of the 
immune system 
Uncomplicated UTIª: 
Amoxicillin  
 
11 ̶ 15  
 
BIDc/ TIDd 
 
5 ̶ 7 
Complicated UTIª: 
Amoxicillin/Clavulanic acid 
 
12.5 ̶ 20 
 
BIDc/ TIDd 
 
5 ̶ 28 
Abscess Antibiotic therapy is only Amoxicillin   15 ̶ 20 BIDc 5 ̶ 7 
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indicated if signs of 
generalization, poor general 
condition, severely 
contaminated wounds, and/ 
or proximity to delicate 
tissues (e.g., joints) are 
present 
Amoxicillin/Clavulanic acid  12.5 ̶ 20  BIDc 5 ̶ 7   
Cefalexin  20 ̶ 30  BIDc/ TIDd 5 ̶ 7   
Clindamycin   10 ̶ 15  BIDc 5 ̶ 7   
Cefazolin 20  BIDc 5 ̶ 7   
ªUTI, urinary tract infection; bSID, once daily; cBID, twice daily; dTID, three times daily 
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Table 3: Justification score (JS)a used to compare antimicrobial prescription to consensus guidelines 
Justification score Explanation 
1 Indication, antimicrobial class, dose and treatment duration in complete accordance with the 
guidelines 
2 Antibiotic therapy indicated but duration
b and/or dosec of treatment not in accordance with the 
guidelines 
3 Antibiotic therapy indicated but antimicrobial class was not in accordance with the guidelinesd 
4 Complete discrepancy with the guidelines, i.e. antibiotics were prescribed without indication or, 
conversely, antibiotics were not prescribed despite being indicated 
aModified from De Pestel et al., 2014 [44]; bA margin of one day shorter or longer was tolerated; cA deviation of up to 20% 
above or below the recommended dose was accepted; dEach case was scored only once. If the dose or duration of 
treatment as well as the antibiotic class were deviating from the guidelines, the case was categorized as JS-3 
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Table 4: Characteristics of cats with aURTD, FLUTD and abscesses presented to university hospitals or private 
practices 
Parameter  aURTDª FLUTD
b
 Abscesses 
  University 
hospitals 
Private 
practices 
p-value University 
hospitals 
Private 
practices 
p-value Private 
practices 
Total number of cases n=43 n=184  n=130 n=203  n=216 
Sex Female 17 (40%) 82 (45%) n.s.
 
43 (33%) 97 (48%) 0.006 64 (30%) 
 Male 24 (55%) 97 (53%)  87 (67%) 104 (51%)  148 (68%) 
 Unknown 2 (5%) 5 (1%)  0 (0%) 2 (1%)  4 (2%) 
Age (years)  Median (range; 
CI) 
5 (0.042 ̶ 16; 
2, 9) 
2 (0.06 ̶ 19; 
1, 4) 
n.s.  7, (1 ̶ 21; 7, 9) 8 (0.17 ̶ 20; 
6, 9) 
n.s. 7 (1 ̶ 18; 6, 8) 
Breed Purebred
 
11 (26%) 33 (18%) n.s.
 
36 (28%) 33 (16%) 0.026 14 (6%) 
 Mixed breed 29 (67%) 143 (78%)  90 (69%) 157 (77%)  190 (88%) 
 Unknown 3 (7%) 8 (4%)  4 (3%) 13 (7%)  12 (6%) 
Vaccinated Yes
 
14 (33%) 28 (15%) n.s.
 
n.a.
c 
n.a.
c 
n.a.
c
 n.a.
c 
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 No 17 (39%) 50 (27%)  n.a.
c
 n.a.
c
  n.a.
c
 
 Unknown 12 (28%) 106 (58%)  n.a.
c 
n.a.
c 
 n.a.
c 
ªaURTD, acute upper respiratory tract disease; bFLUTD, feline lower urinary tract disease; cNot applicable 
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Table 5: Diagnostic work-up and antibiotic prescription in aURTDa cases presented to university hospitals or 
private practices 
Parameter  University hospitals Private practices p-value 
Total number of cases  n=43 n=184  
Diagnostic work-up with PCR
b
 Yes
c 
25 (58%) 2 (1%) <0.001 
At least one symptom listed in the guidelines
d 
Yes
c 
29 (68%) 37 (21%) <0.001 
Unknown 1 (3%) 42 (23%)  
Hospitalization Yes
c 
31 (72%) 5 (3%) <0.001 
Pre-treated with antibiotics Yes
c 
13 (30%) 8 (4%) <0.001 
 Unknown 2 (5%) 4 (2%)  
Antibiotic therapy Yes
c 
31 (72%) 144 (78%) n.s. 
Antibiotic classes Potentiated aminopenicillins  28 (90%) 42 (29%) <0.001 
 Third generation cephalosporins 2 (6%) 47 (33%) 0.002 
 Aminopenicillins 1 (3%) 40 (28%) 0.002 
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 Tetracyclines 2 (6%) 26 (18%) n.s.
 
 Fluoroquinolones 1 (3%) 6 (4%) n.s.
 
 Amphenicols 0 (0%) 3 (2%) n.s 
 
 Macrolides 0 (0%) 3 (2%) n.s 
 
 First generation cephalosporins 0 (0%) 1 (1%) n.s 
 
 Penicillins 0 (0%) 1 (1%) n.s.
 
Combination or serial therapy
e
 Yes
c 
4 (13%) 21 (15%) n.s.
 
Critically important antibiotic
e 
Yes
c 
3 (10%) 55 (38%) 0.001 
Duration of therapy (days) Median (range) 12 (4  ̶  27) 10 (4  ̶  37) n.s.  
Justification score
e 
1  12 (28%) 37 (20%) n.s.
 
 2 1 (2%) 3 (2%) n.s.
 
 3 26 (61%) 22 (12%) <0.001 
 4 3 (7%) 80 (43%) <0.001 
 Judgement not possible 1 (2%) 42 (23%) 0.001 
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aaURTD, acute upper respiratory tract disease; bPCR, polymerase chain reaction; cValues for the category “no” are not 
shown since it is the reference group; dPoor general condition, fever, lethargy and/ or anorexia; eAs defined in methods 
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Table 6: Diagnostic work-up and antibiotic prescription in FLUTDa cases presented to university hospitals or 
private practices  
Parameter  University hospital Private practice p-value 
Total number of cases  n=130 n=203  
Urine analysis performed Yes
b 
119 (92%) 55 (27%) <0.001 
   Sediment analysis Yes
b 
93 (72%) 50 (25%) <0.001 
   Bacterial culture Yes
b 
113 (87%) 20 (10%) <0.001 
Confirmed bacterial etiology
c
 Yes
b 
45 (35%) 16 (8%) <0.001 
Hospitalization Yes
b 
90 (69%) 30 (15%) <0.001 
Pre-treated with antibiotics Yes
b 
23 (18%) 4 (2%) <0.001 
 Unknown 5 (4%) 3 (2%)  
Antibiotic therapy Yes
b 
85 (65%) 115 (57%) n.s. 
   Antibiotic classes Potentiated aminopenicillins 71 (84%) 50 (57%) <0.001 
 Third generation cephalosporins   7 (8%) 44 (38%) <0.001 
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 Fluoroquinolones 5 (6%) 20 (17%) 0.017 
 Aminopenicillins 1 (1%) 22 (19%) <0.001 
 First generation cephalosporins 5 (6%) 1 (1%) n.s  
 Amphenicols 1 (1%) 0 (0%) n.s  
 Tetracyclines 1 (1%) 0 (0%) n.s  
Combination or serial therapy
d 
Yes
b 
6 (7%) 20 (17%) n.s. 
Critically important antibiotic
d 
Yes
b 
12 (14%) 62 (54%) <0.001 
Duration of therapy (days) Median (range) 13 (1  ̶  56) 9 (1  ̶  42) 0.012   
Justification score
d 
1  57 (44%) 24 (12%) <0.001 
 2 1 (1%) 0 (0%) n.s. 
 3 22 (17%) 9 (4%) <0.001 
 4 39 (30%) 11 (6%) <0.001 
 Judgement not possible 11 (8%) 159 (78%) <0.001 
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aFLUTD, feline lower urinary tract disease; bValues for the category “no” are not shown since it is the reference group; 
cDefined as either positive urine sediment analysis or positive bacterial culture; dAs defined in methods 
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Table 7: Clinical signs, wound treatment and antibiotic prescription in cases with abscesses presented to private 
practices  
Parameter  Private practice 
Total number of cases  n=216 
At least one symptom listed in the guidelines
a 
Yes
b 
65 (30%) 
 Unknown 85 (39%) 
Local wound treatment Yes
b 
156 (72%) 
 Unknown 12 (6%) 
Drain placement Yes
b 
33 (15%) 
Antibiotic therapy Yes
b 
207 (96%) 
   Antibiotic classes Potentiated aminopenicillins  132 (64%) 
 Third generation cephalosporins 52 (25%) 
 Aminopenicillins 50 (24%) 
 First generation cephalosporins 12 (6%) 
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 Fluoroquinolones 5 (3%) 
 Lincosamides 4 (2%) 
 Penicillins 1 (1%) 
Combination or serial therapy
c 
Yes
b 
48 (24%) 
Critically important antibiotic
c 
Yes
b 
57 (28%) 
Duration of therapy (days)  7 (1  ̶  24) 
Justification score
c 
1  36 (17%) 
 2 16 (7%) 
 3 14 (7%) 
 4 65 (30%) 
 Judgement not possible 85 (39%) 
aSigns of generalization, poor general condition, severely contaminated wounds, and/ or proximity to delicate tissues; 
bValues for the category “no” are not shown since it is the reference group; cAs defined in methods 
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